Efficacy and Safety of Vascana® in Subjects With Secondary Raynaud's Phenomenon
Clinical trial NCT02688270 · COMPLETED
Trial details
- NCT number
- NCT02688270
- Sponsor
- Covis Pharma S.à.r.l.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2016-12-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.